| Document |
Document Title |
|
WO/2003/082358A1 |
The invention relates to the use of glass and/or glass ceramics in the form of powder and/or fibers having a total glass composition that comprises at least one ion that is released in an aqueous solution. The invention is characterized ...
|
|
WO/2003/082914A1 |
The invention relates to snake venom protease polypeptides and nucleic acid sequences encoding same. This invention also relates to methods of making and using the snake venom proteases, e.g., to promote haemostasis and prevent blood los...
|
|
WO/2003/082163A1 |
The present invention relates to drug delivery devices for moist tissue, in particular mucosal tissue and tissue in the serous cavities, as well as a method of its use. The devices, which contain NOCC, are adherent to the mucosal tissue,...
|
|
WO/2003/077964A1 |
The invention provides absorbent hydrogel compositions and hydrogel-containing structures. Typically, a first portion of the novel materials comprises a porous flexible plasticised hydrophilic polymer matrix having an internal cellular s...
|
|
WO/2003/075970A1 |
The protective film with enhanced adhesion to the skin constitutes of a modified compound on the basis of a alcoholic polyvinilalchol solution of the following proportion: 1 to 50 weight perc. of polyvinilalcohol, 5 to 70 weight perc. of...
|
|
WO/2003/075886A1 |
It is intended to provide an external medicine for wounds which has nonconventional convenience in treating skin damages accompanied by a large amount of an exudation such as bedsore, skin ulcer and burn and yet has such advantages as ob...
|
|
WO/2003/075968A2 |
Polymer mini-emulsions are provided comprising a dispersed phase which comprises particles of a biocompatible hydrophilic polymer and having an average particle size between 50 and 750 nm, the polymer particles comprising a polymer of at...
|
|
WO/2003/063923A1 |
A wound dressing is provided that is formed $i(in situ) on the wound by spray application of a composition including a composition that gels $i(in situ) to form a hydrogel. The composition preferably includes macromers having water solub...
|
|
WO/2003/061721A1 |
Film-forming compositions, as well as methods of making and using, wherein the compositions include an optional active agent, water, a surfactant, and a water-soluble or water-dispersible vinyl polymer comprising amine group-containing s...
|
|
WO/2003/061538A1 |
A wound dressing consisting essentially of a free−flowing, substantially anhydrous particulate material, wherein the particulate material forms a water−soluble hydrogel in contact with water. In use, the dressing is sprinkled onto an...
|
|
WO/2003/059404A2 |
Preparation for wound healing and prevention of adhesion to the wound containing a physiologically acceptable salt of hyaluronic acid, iodine and potassium iodine.
|
|
WO/2003/057865A1 |
The invention relates to a composition for creating regenerating and repairing tissues. The inventive composition comprises: a platelet concentrate which contains fibrinogen and concentrations of platelet growth factors (PDGFs); and othe...
|
|
WO/2003/055536A1 |
A wound care device for local treatment of pain in a wound comprising an active pain relieving composition, wherein said composition is an anti-inflammatory pain killing agent. The wound care device is suitable for treatment of pain in o...
|
|
WO/2003/051408A1 |
The invention provides a hydrogel composition comprising a plasticised cross-linked hydrophilic polymer of acryloyl morpholine and optionally one or more comonomers.
|
|
WO/2003/051331A1 |
The present relates to the prophylaxis and treatment of wounds such as decubitus ulcers and burns by the administration of an active substance which causes an increased concentration of melanin, melanin precursor, melanin derivatives, me...
|
|
WO/2003/047530A2 |
Provided are supplemented and unsupplemented, ready-to-use and instantly-available fibrin sealants ('FS'), prepared from ready-to-use, storage-stable, concentrated liquid fibrinogen preparations. The thus-produced FS product when applied...
|
|
WO/2003/045452A1 |
Medical dressings treated with one or more poloxamers show reduced tendency to adhere to the wound interface on removal, thereby reducing traumatisation and promoting healing.
|
|
WO/2003/041686A2 |
Disclosed are methods and formulations for the treatment of topical conditions on mammalian tissues such as skin and mucous tissues mediated at least in part by viral, bacterial or fungal infections in the mammal. The methods of this inv...
|
|
WO/2003/034993A2 |
A composition and method for facilitating the growth, protection and healing of tissues and cells in animals and humans. Formulated as either a powder, gel, paste, film, fluid injectable, rehydratable freeze-dried paste or sponge, spraya...
|
|
WO/2003/035124A2 |
A bioactive material is made using fibroin solutions and suspensions that can be used alone or as a composite with particles such as core/shell particles. The material is designed to support the constructions, repair, regeneration or aug...
|
|
WO/2003/026710A1 |
A novel mixture for use in combination with a protective dressing for the topical treatment of bleeding wounds, in particular minor or mild bleeding wounds, comprises: a pharmaceutically efficacious amount of an anesthetic being preferab...
|
|
WO/2003/026709A1 |
A novel liquid mixture for use as dressing spray for the treatment of bleeding wounds comprises a pharmaceutically efficacious amount of an anesthetic being either benzocaine or pramoxine hydrochloride, a pharmaceutically efficacious amo...
|
|
WO/2003/024495A1 |
A medical implant that delivers therapeutic via microtubes and a method of making the same is provided. In one embodiment a biologically implantable structure adapted to fit within the body of a patient is provided. This structure may ha...
|
|
WO2002017980A9 |
The present invention provides the use and composition of matter of angiogenic or other growth factors expressed by combining various types and stages of differentiation of allogeneic human cell strains or lines in unencapsulated pastes ...
|
|
WO/2003/020328A1 |
A drainage bag for receiving bodily waste, such as an ostomy bag, comprises an outer bag of material soluble in cold water,e.g. polyvinyl alcohol, and an inner bag of material insoluble in water at ambient temperature and body temperatur...
|
|
WO/2003/017913A1 |
A method, apparatus and kit for preparing and performing a surgical procedure includes providing a medicinal composition having an autologous tissue medium and a therapeutic agent. the medicinal composition is then delivered to a surgica...
|
|
WO/2003/017989A1 |
A therapeutic medical article is provided which comprises a medical article, a precursor compound and an activor compound. The medical article is adapted, upon administration to a patient, to release the precursor compound and the activa...
|
|
WO/2003/017826A2 |
Disclosed herein are novel injectable, biocompatible compositions, preferably, comprising a combination of particulate, processed tissue and a carrier. Specifically disclosed are compositions comprising acellular, pulverized dermis combi...
|
|
WO/2003/013630A2 |
Embolic devices and methods for mixing and delivering embolic material in a sterile environment facilitate delivery of the embolic material directly into a patient thereby preventing the embolic material from becoming contaminated. Such ...
|
|
WO/2003/009877A1 |
A composition comprising a non-volatile silicone fluid in admixture with fumed silica and a pharmaceutical active agent.
|
|
WO2001068123A9 |
The present invention relates to methods of modulating cell migration, particularly, monocyte, neutrophil or macrophage migration, using galectin-3, galectin-3 binding polypeptide, or galectin-3 receptor binding polypeptide. Specifically...
|
|
WO/2003/002168A1 |
Described are hemostasis devices useful for implantation in biopsy tracts, which devices comprise highly compact, dried hemostatic sponge elements. Preferred devices also include compacted sponge matrices exhibiting high density and rigi...
|
|
WO/2003/002165A1 |
The invention provides tissue graft compositions comprising collagen-based extracellular matrices derived from renal capsules of warm-blooded vertebrates. The invention further provides a process of harvesting and purifying a renal capsu...
|
|
WO/2003/000155A2 |
The invention described herein relates to methods for reducing and/or stopping bleeding or fluid loss from open wound, denuded tissue, or burned skin, comprising the step of applying to the open wound, denuded tissue or burned skin a gel...
|
|
WO/2002/100383A1 |
The invention comprises a porous sponge-like cellulosic material to be used in treatment of injuries and/or burns. The cellulosic material comprises zinc, copper, selenium and/or iron bound to and/or absorbed into the material matrix in ...
|
|
WO/2002/100453A1 |
A crosslinkable macromer system and related methods of preparing the system and using the system in the form of a crosslinked matrix between a tissue site and an implant article such as a tissue implant or on the porous surface of a pros...
|
|
WO/2002/091999A2 |
It has been discovered that increasing telomerase activity in cells surrounding a wound has a variety of effects that enhance wound healing. Replication capacity is enhanced, and the mobility of the epithelial cells can be increased by 3...
|
|
WO/2002/089737A2 |
A method is described for separating, retrieving and concentrating platelets from whole blood relying on aggregation of the platelets followed by filtration. This method eliminates the need of a centrifuge for separating said cells from ...
|
|
WO/2002/085262A1 |
A means for the surgical restoration of an intervertebral disc alternatively comprising a polymeric or polymerisable biocompatible material and a means of introducing said material into the internal cavity of said intervertebral disc, wh...
|
|
WO2002067788B1 |
Stabilizing an object (106) in the body of a patient involves the injection of a lower critical solution temperature (LCST) material or other flowable material into the body of the patient so that the material contacts the object. The LC...
|
|
WO/2002/080941A1 |
Compositions comprising a granular mixture containing a water-soluble acid, a thickener and a water-soluble dispersant as the essential components wherein the thickener is mixed with the water-soluble acid and the water-soluble dispersan...
|
|
WO/2002/080991A2 |
A centrifuge system is disclosed for the formation of an autologous platelet gel wherein all of the blood components for the gel are derived from a patient to whom the gel is to be applied. First a platelet rich plasma and a platelet poo...
|
|
WO/2002/078728A2 |
The present invention provides the use of a peptide derivative having the sequence X-NH-Gly-Pro-Ala-Gly-CO-Y, wherein X is H or a pharmaceutically acceptable N-terminal group, and Y is OH or a pharmaceutically acceptable C-terminal group...
|
|
WO/2002/078755A2 |
A medical dressing comprising a silver compound and being capable of releasing antimicrobial silver ion activity in the range of 50 - 10000 micrograms per cm?2¿ dressing to a wound and, at the same time, being capable of absorbing more ...
|
|
WO/2002/072076A1 |
This invention relates to hemostatic therapeutic compositions and, more particularly to methods for bringing about rapid, painless hemostasis intraorally, for dermatological applications or all other hemostasis applications. 100 to 300 m...
|
|
WO/2002/072128A1 |
Disclosed is a biocompatible, hemostatic, cross-linked gelatin composition comprising a biocompatible material comprising cross-linked gelatin and a sufficient amount of wetting agent to permit uniform wetting of the sponge in the presen...
|
|
WO/2002/072112A1 |
The invention relates to the use of selenite or preparations containing selenite, mixed with pharmaceutically acceptable or food compatible acids for producing an agent for treating wounds.
|
|
WO/2002/071994A1 |
Hydrogels that expand volumetrically in response to a change in their environment (e.g., a change in pH or temperature) and their methods of manufacture and use. Generally, the hydrogels are prepared by forming a liquid reaction mixture ...
|
|
WO/2002/067876A1 |
Disclosed is a topical prepartion for the treatment of open wounds and ulcers in humans and animals. the said composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbai, Opuntia, Dilaong. It also contains $g(b)beta-sit...
|
|
WO/2002/064182A2 |
A porous, water-absorbing fleece is made from crosslinkable biocompatible and biodegradable macromers. A solution of the macromers is frozen and vacuum-dried through lyophilization. The 'fleece' formed by lyophilization is then crosslink...
|
